RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Larsen, Martin J ^a,b   Thomassen, Mads ^a,b   Tan, Qihua ^a,b   Lænkholm, Anne Vibeke ^c   Bak, Martin ^a   Sørensen, Kristina P ^a,b   Andersen, Mette Klarskov ^d   Kruse, Torben A ^a,b   Gerdes, Anne Marie ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

^d University of Copenhagen   (Denmark)

Author keywords

Gene expression analysis; Hereditary breast and ovarian cancer syndrome; Microarray analysis; Molecular subtypes; non BRCA1 2; Promoter methylation; RNA profiling

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CLUSTER ANALYSIS; DNA METHYLATION; EPIGENESIS, GENETIC; FAMILY; FEMALE; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84893192370     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-9     Document Type: Article

References (38)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families. Gerdes A-M, Cruger DG, Thomassen M, Kruse TA, Clin Genet 2006 69 171 178 10.1111/j.1399-0004.2006.00568.x 16433698 (Pubitemid 43372282)
3. The complex genetic landscape of familial breast cancer. Melchor L, Benítez J, Hum Genet 2013 132 845 863 10.1007/s00439-013-1299-y 23552954
4. A genome wide linkage search for breast cancer susceptibility genes. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, ChenevixTrench G, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, StoppaLyonnet D, Couch F, Hopper JL, Giles GG, McCredie MRE, Buys S, Andrulis I, Senie R, Goldgar DE, Oldenburg R, KroezeJansema K, Kraan J, MeijersHeijboer H, Klijn JGM, Van Asperen C, Van Leeuwen I, Vasen HFA, Cornelisse CJ, Genes Chromosom Cancer 2006 45 646 655 16575876 (Pubitemid 43727152)
5. Genome-wide Linkage scan reveals three putative breast-cancer- susceptibility Loci. Rosa-Rosa JM, Pita G, Urioste M, Llort G, Brunet J, Lázaro C, Blanco I, Ramón Y, Cajal T, Díez O, De La Hoya M, Caldés T, Tejada M-I, González-Neira A, Benítez J, Am J Hum Genet 2009 84 115 122 10.1016/j.ajhg.2008.12.013 19147119
6. Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families. Arason A, Gunnarsson H, Johannesdottir G, Jonasson K, Bendahl P-O, Gillanders E, Agnarsson B, Jonsson G, Pylkas K, Mustonen A, Heikkinen T, Aittomaki K, Blomqvist C, Melin B, Johannsson O, Moller P, Winqvist R, Nevanlinna H, Borg A, Barkardottir R, Breast Cancer Res 2010 12 50 10.1186/bcr2608 20637093
7. Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer. Snape K, Ruark E, Tarpey P, Renwick A, Turnbull C, Seal S, Murray A, Hanks S, Douglas J, Stratton M, Rahman N, Breast Cancer Res Treat 2012 134 1 429 433 10.1007/s10549-012-2057-x 22527104
8. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, Duran M, Osorio A, Moreno L, Gonzalez-Neira A, Rosa-Rosa JM, Sinilnikova O, Mazoyer S, Hopper J, Lazaro C, Southey M, Odefrey F, Manoukian S, Catucci I, Caldes T, Lynch HT, Hilbers FSM, Van Asperen CJ, Vasen HFA, Goldgar D, Radice P, Devilee P, Benitez J, PLoS ONE 2013 8 55681 10.1371/journal.pone.0055681 23409019
9. Exome sequencing of Germline DNA from Non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling. Hilbers FS, Meijers CM, Laros JFJ, Van Galen M, Hoogerbrugge N, Vasen HFA, Nederlof PM, Wijnen JT, Van Asperen CJ, Devilee P, PLoS ONE 2013 8 55734 10.1371/journal.pone.0055734 23383274
10. Genetic predisposition to breast cancer: past, present, and future. Turnbull C, Rahman N, Annu Rev Genomics Hum Genet 2008 9 321 345 10.1146/annurev.genom.9.081307.164339 18544032
11. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva I, Dos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans DG, Fenlon DF, Flanagan JM, Foster C, Breast Cancer Res 2013 15 92 10.1186/bcr3493 24286369
12. Phenotype-genotype correlation in familial breast cancer. Vargas AC, Reis-Filho JS, Lakhani SR, J Mammary Gland Biol Neoplasia 2011 16 27 40 10.1007/s10911-011-9204-6 21400086
13. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TVO, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, et al. Cancer Epidemiology Biomarkers & Prevention 2012 21 134 147 10.1158/1055-9965.EPI- 11-0775
14. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, Van De Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BAJ, Futreal PA, Peto J, Stoppa-Lyonnet D, Bignon Y-J, Struewing JP, Bishop DT, Klijn JGM, Devilee P, Cornelisse CJ, et al. Clin Cancer Res 2000 6 782 789 10741697 (Pubitemid 30159330)
15. Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascón A, Urioste M, Cazorla A, Díez O, Lerma E, Esteller M, Palacios J, Benitez J, Mod Pathol 2007 20 1298 1306 10.1038/modpathol.3800969 17885670 (Pubitemid 350126855)
16. Repeated observation of breast tumor subtypes in independent gene expression data sets. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale A-L, Botstein D, Proc Natl Acad Sci USA 2003 100 8418 8423 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
17. The molecular portraits of breast tumors are conserved across microarray platforms. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Orrico AR, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, et al. BMC Genomics 2006 7 96 10.1186/1471-2164-7-96 16643655 (Pubitemid 43786485)
18. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Yu K, Lee CH, Tan PH, Tan P, Clin Cancer Res 2004 10 5508 5517 10.1158/1078-0432.CCR-04-0085 15328190 (Pubitemid 39100489)
19. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale A-L, Proc Natl Acad Sci USA 2001 98 10869 10874 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
20. Supervised risk predictor of breast cancer based on intrinsic subtypes. Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS, J Clin Oncol 2009 27 1160 1167 10.1200/JCO.2008.18.1370 19204204
21. Molecular portraits of human breast tumours. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale A-L, Brown PO, Botstein D, Nature 2000 406 747 752 10.1038/35021093 10963602
22. Subtypes of familial breast tumours revealed by expression and copy number profiling. Waddell N, Arnold J, Cocciardi S, Da Silva L, Marsh A, Riley J, Johnstone CN, Orloff M, Assie G, Eng C, Reid L, Keith P, Yan M, Fox S, Devilee P, Godwin AK, Hogervorst FBL, Couch F, Grimmond S, Flanagan JM, Khanna K, Simpson PT, Lakhani SR, Chenevix-Trench G, Breast Cancer Res Treat 2010 123 661 677 10.1007/s10549-009-0653-1 19960244
23. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Jönsson G, Staaf J, Vallon-Christersson J, Ringnér M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkilä P, Aittomäki K, Blomqvist C, Loman N, Malmström P, Olsson H, Th Johannsson O, Arason A, Nevanlinna H, Barkardottir RB, Borg A, Breast Cancer Res 2010 12 42 10.1186/bcr2596 20576095
24. Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling. Larsen MJ, Kruse TA, Tan Q, Lænkholm A-V, Bak M, Lykkesfeldt AE, Sørensen KP, Hansen TVO, Ejlertsen B, Gerdes A-M, Thomassen M, PLoS ONE 2013 8 64268 10.1371/journal. pone.0064268 23704984
25. Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes. Nagel JHA, Peeters JK, Smid M, Sieuwerts AM, Wasielewski M, De Weerd V, Trapman-Jansen AMAC, Van Den Ouweland A, Brüggenwirth H, Jcken WFJ VI, Klijn JGM, Van Der Spek PJ, Foekens JA, Martens JWM, Schutte M, Meijers-Heijboer H, Breast Cancer Res Treat 2012 132 439 448 10.1007/s10549-011-1588-x 21614566
26. Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Hedenfalk I, Ringnér M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J, Proc Natl Acad Sci USA 2003 100 2532 2537 10.1073/pnas.0533805100 12610208 (Pubitemid 36297533)
27. Transcriptional characteristics of familial nonBRCA1/BRCA2 breast tumors. FernándezRamires R, Gómez G, MuñozRepeto I, De Cecco L, Llort G, Cazorla A, Blanco I, Gariboldi M, Pierotti MA, Benítez J, Osorio A, Int J Cancer 2011 128 2635 2644 10.1002/ijc.25603 20715112
28. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Melchor L, Honrado E, García MJ, Alvarez S, Palacios J, Osorio A, Nathanson KL, Benítez J, Oncogene 2008 27 3165 3175 10.1038/sj.onc.1210975 18071313 (Pubitemid 351693170)
29. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Jönsson G, Staaf J, Vallon-Christersson J, Ringnér M, Gruvberger-Saal SK, Saal LH, Holm K, Hegardt C, Arason A, Fagerholm R, Persson C, Grabau D, Johnsson E, Lövgren K, Magnusson L, Heikkilä P, Agnarsson BA, Johannsson OT, Malmström P, Fernö M, Olsson H, Loman N, Nevanlinna H, Barkardottir RB, Borg A, Cancer Res 2012 72 4028 4036 10.1158/0008-5472.CAN-12-0097 22706203
30. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors. Joosse SA, Brandwijk KIM, Mulder L, Wesseling J, Hannemann J, Nederlof PM, Genes Chromosom Cancer 2011 50 71 81 10.1002/gcc.20833 21104783
31. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Joosse SA, Brandwijk KIM, Devilee P, Wesseling J, Hogervorst FBL, Verhoef S, Nederlof PM, Breast Cancer Res Treat 2012 132 379 389 10.1007/s10549-010-1016-7 20614180
32. Gene-expression profiles in hereditary breast cancer. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty E, Kononen J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johannsson O, Olsson H, Wilfond B, Sauter G, Kallioniemi O-P, Borg A, Trent J, N Engl J Med 2001 344 539 548 10.1056/NEJM200102223440801 11207349 (Pubitemid 32167867)
33. Gene expression profiling predicts clinical outcome of breast cancer. Veer LJ V 't, Dai H, Van De Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, Van Der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH, Nature 2002 415 530 536 10.1038/415530a 11823860 (Pubitemid 34130608)
34. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, Honrado E, Rodríguez R, Urioste M, Valle L, Díez O, Cigudosa JC, Dopazo J, Esteller M, Benitez J, Clin Cancer Res 2005 11 1146 1153 15709182 (Pubitemid 40175764)
35. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Collins N, Wooster R, Stratton MR, Br J Cancer 1997 76 1150 1156 10.1038/bjc.1997.526 9365162 (Pubitemid 27448010)
36. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, Da Silva L, Vargas AC, Reid L, Simpson PT, Lakhani SR, Chenevix-Trench G, J Pathol 2010 221 452 461 20593485
37. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, Van Asperen CJ, Hoogerbrugge N, Van Leeuwen I, Vasen HFA, Cleton-Jansen A-M, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P, Clin Cancer Res 2006 12 1693 1700 10.1158/1078-0432.CCR-05-2230 16551851
38. A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients. Didraga MA, Van Beers EH, Joosse SA, Brandwijk KIM, Oldenburg RA, Wessels LFA, Hogervorst FBL, Ligtenberg MJ, Hoogerbrugge N, Verhoef S, Devilee P, Nederlof PM, Breast Cancer Res Treat 2011 130 425 436 10.1007/s10549-011-1357-x 21286804